Načítá se...
Malaria research and its influence on anti-malarial drug policy in Malawi: a case study
BACKGROUND: In 1993, Malawi changed its first-line anti-malarial treatment for uncomplicated malaria from chloroquine to sulfadoxine-pyrimethamine (SP), and in 2007, it changed from SP to lumefantrine-artemether. The change in 1993 raised concerns about whether it had occurred timely and whether it...
Uloženo v:
| Vydáno v: | Health Res Policy Syst |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4888534/ https://ncbi.nlm.nih.gov/pubmed/27246503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12961-016-0108-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|